RT Journal Article
SR Electronic
T1 Brief remote psychological treatments for healthcare workers with emotional distress during the SARS-CoV-2 pandemic: a randomized clinical trial
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.09.04.24313084
DO 10.1101/2024.09.04.24313084
A1 Salum, Giovanni Abrahão
A1 de Abreu Costa, Marianna
A1 Spanemberg, Lucas
A1 Simioni, André Rafael
A1 Gosmann, Natan Pereira
A1 de Souza, Lívia Hartmann
A1 Cuijpers, Pim
A1 Pine, Daniel Samuel
A1 Brunoni, André Russowsky
A1 Kristensen, Christian Haag
A1 de Almeida Fleck, Marcelo Pio
A1 Manfro, Gisele Gus
A1 Dreher, Carolina Blaya
YR 2024
UL http://medrxiv.org/content/early/2024/09/05/2024.09.04.24313084.abstract
AB BACKGROUND The SARS-CoV-2 pandemic has catalyzed a widespread mental health crisis, impacting millions of people. This study aimed to compare three brief remote psychological treatments for healthcare workers with emotional distress during the SARS-CoV-2 pandemic.METHODS Nationwide three-arm randomized clinical trial in Brazil. This is a transdiagnostic study that included professionals and students from health services with high levels of anxiety, depression, or irritability symptoms, as defined by Patient-Reported Outcomes Measurement Information System (PROMIS). The exclusion criterion was positive suicide risk. Participants were randomized single session psychoeducation group plus weekly personalized pre-recorded videos for four weeks (SSI-ET), brief cognitive behavioral telepsychotherapy group (B-CBT, four sessions), or brief interpersonal telepsychotherapy (B-IPT, four sessions). This study was registered in clinicaltrials.gov (NCT04635618). The primary outcome was the proportion of participants with a 50% reduction in T-scores in PROMIS rating scales of anxiety, depression, and/or irritability at one-month.FINDINGS Of the 3328 volunteers assessed for eligibility, 999 participants were enrolled, from May 19th 2020 to December 31st 2021, and allocated to SSI-ET (n=342), B-CBT (n=323), or B-IPT (n=334). All three groups showed significant symptom reductions in the one-month assessment that were maintained over the three and six-month follow-ups (Cohen’s d range = 0.94-1.36, p<0.001), with no significant difference between groups. The estimated proportion of responders were 46.5%, 43.7% and 44.6% for SSI-ET, B-CBT and B-IPT, respectively.Conclusions Our results refute the hypothesis that therapeutic interventions with higher number of sessions and with more specialized therapeutic components offer advantages in alleviating emotional distress, particularly among healthcare workers facing epidemic emergencies. These results have critical implications for planning interventions for crisis responses, especially in settings with limited resources.FUNDING Ministry of Health of Brazil, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico, and Fundo de Incentivo à Pesquisa/Hospital de Clínicas de Porto Alegre.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialClinicalTrials.gov, NCT04635618Funding StatementThis study was funded in part by the Ministry of Health of Brazil through, the decentralized execution term No. 16/2020, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Finance Code 001, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - 001), Brazilian federal government agencies, and Fundo de Incentivo a Pesquisa/Hospital de Clinicas de Porto Alegre (FIPE/HCPA - 001), Brazil.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The trial protocol was approved by the National Research Ethics Commission (CONEP).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesIndividual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices) and the study protocol will be available immediately following publication with no end date. Researchers who provide a methodologically sound proposal may gain access to the database to achieve aims in the approved proposal. Proposals should be directed to gsalum{at}hcpa.edu.br and, to gain access, data requestors will need to sign a data access agreement. After 36 months, data will be available for 5 years at our university's data warehouse (https://lume.ufrgs.br), but without investigator support other than deposited metadata. https://lume.ufrgs.br